Natera Net Income 2014-2024 | NTRA

Natera annual/quarterly net income history and growth rate from 2014 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Natera net income for the quarter ending September 30, 2024 was $-0.032B, a 71.02% decline year-over-year.
  • Natera net income for the twelve months ending September 30, 2024 was $-0.215B, a 57.01% decline year-over-year.
  • Natera annual net income for 2023 was $-0.435B, a 20.63% decline from 2022.
  • Natera annual net income for 2022 was $-0.548B, a 16.13% increase from 2021.
  • Natera annual net income for 2021 was $-0.472B, a 105.32% increase from 2020.
Natera Annual Net Income
(Millions of US $)
2023 $-435
2022 $-548
2021 $-472
2020 $-230
2019 $-125
2018 $-128
2017 $-138
2016 $-100
2015 $-70
2014 $-5
2013 $-37
Natera Quarterly Net Income
(Millions of US $)
2024-09-30 $-32
2024-06-30 $-37
2024-03-31 $-68
2023-12-31 $-78
2023-09-30 $-109
2023-06-30 $-111
2023-03-31 $-137
2022-12-31 $-143
2022-09-30 $-121
2022-06-30 $-145
2022-03-31 $-139
2021-12-31 $-141
2021-09-30 $-151
2021-06-30 $-116
2021-03-31 $-64
2020-12-31 $-76
2020-09-30 $-58
2020-06-30 $-60
2020-03-31 $-35
2019-12-31 $-35
2019-09-30 $-23
2019-06-30 $-32
2019-03-31 $-34
2018-12-31 $-32
2018-09-30 $-30
2018-06-30 $-34
2018-03-31 $-33
2017-12-31 $-47
2017-09-30 $-28
2017-06-30 $-29
2017-03-31 $-33
2016-12-31 $-42
2016-09-30 $-26
2016-06-30 $-23
2016-03-31 $-9
2015-12-31 $-23
2015-09-30 $-18
2015-06-30 $-20
2015-03-31 $-10
2014-12-31
2014-09-30 $0
2014-06-30 $-1
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $20.871B $1.083B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Viatris (VTRS) United States $14.478B 4.46
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
Charles River Laboratories (CRL) United States $9.314B 18.00
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00